On 21 May 2026, Lilly announced positive topline results from TRIUMPH-1 (not yet peer-reviewed), the pivotal Phase 3 obesity trial
Orphanet Journal of Rare Diseases
However, it is also important to highlight, that the ability of EWcp to the regulate alcohol consumption patterns is not limited to the peptidergic CART/UCN1 neurons, as the glutamatergic neurons may also contribute 56
Plaintiffs must demonstrate clear causation between their Ozempic use and conditions necessitating treatment, with objective diagnostic evidence carrying particular weight after Judge Marstons August 2025 ruling requiring gastric emptying studies for gastroparesis claims
The right approach depends on your natural shape and the result you want to see in the mirror
GSK3, glycogen synthase kinase 3